Skip to content

To compare the pain managing property in Piles of Patha Churn and Yawani Churna (Herbal Remedies) with tab.diclofenac sodium and serratopeptidase (Painkiller Tablets)

RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHA CHURN WITH YAWANI CHURN COMPARED TO TABLET DICLOFENAC SODIUM (50 mg ) AND SERRATIOPEPTIDASE (10 mg ) IN THE PAIN MANAGEMENT OF SHUSHKARSH - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089703
Enrollment
80
Registered
2025-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

Tilak Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants having classical symptom of shushkarsha(pain,hard stool,constipation) will be taken as subject to study Participants of 1 and 2 nd degree piles Participants of age between 20-60 years were taken Selection of participants will be irrespective of sex, socio -economic class, religion

Exclusion criteria

Exclusion criteria: Participants suffering from Shushkarsha associated with following disease will be excluded Known case of bleeding disorder Ulcerative collitis Ca rectum 3rd and 4th degree haemorrhoid Pregnancy Participants below 20 and above 60 years are excluded

Design outcomes

Secondary

MeasureTime frame
Decrease in pain of arsha No constipationTimepoint: 7th day

Primary

MeasureTime frame
Mild relief in pain of arsh Mild decrease in constipationTimepoint: 3rd day

Countries

India

Contacts

Public ContactDrSushmita Chavan

Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital

dipakpoman@gmail.com8308612087

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026